# Oryza Pharmaceuticals Inc.: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate... shortage reverified (unavailable from this maker)

**Score:** 45/100

| Field | Value |
|---|---|
| Manufacturer | Oryza Pharmaceuticals Inc. |
| Drug | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet |
| Dosage form | Tablet |
| Therapeutic category | Psychiatry |
| Status | Current |
| Stage | Shortage reverified (still listed) |
| Availability | Unavailable |
| Reason | Shortage of an active ingredient |
| Presentations affected | 5 |
| Package NDCs | 72516-016-01, 72516-011-01, 72516-013-01, 72516-012-01, 72516-014-01 |
| Manufacturer supply note | Estimated recovery: April 2027 |
| First posted | 2022-10-12 |
| Updated | 2026-10-15 |

## Why this score
- Unavailable from this manufacturer.

Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) (https://dps.fda.gov/drugshortages). Last refreshed: 2026-11-05T09:00:14.778Z.
From the openFDA drug shortages endpoint, which mirrors the FDA drug shortage list and can lag it by days. Availability and recovery notes are the manufacturer's own statements to FDA. Company and product level only. Verify with FDA and the manufacturer before acting.